Allurion Technologies(ALUR) - 2025 Q2 - Quarterly Results

Form 8-K: Allurion Technologies, Inc. (August 5, 2025) Item 2.02 Results of Operations and Financial Condition The company announced preliminary unaudited Q2 2025 financial results, emphasizing they are not finalized and may materially differ from final figures - The company announced select preliminary unaudited financial results for the second quarter ended June 30, 2025[7] - These financial results have not yet been finalized by management or reviewed by the company's independent auditors, Deloitte & Touche LLP[8] - The company cautions that subsequent information may lead to material differences from these preliminary results, and investors should not place undue reliance on them[8] Item 2.05 Costs Associated with Exit or Disposal Activities The company adopted a strategic restructuring plan, reducing its workforce by 65% and incurring $1.5 million in charges, to refocus on key strategic areas - A strategic restructuring plan was adopted by the board of directors on July 23, 2025[9] - The company is shifting its focus to low-dose GLP-1 combination therapy, muscle mass maintenance, and U.S. market entry[9] Restructuring Plan Details | Metric | Value | | :--- | :--- | | Workforce Reduction | ~70 employees (~65% of workforce) | | Expected Completion | End of Q3 2025 | | Estimated Charges | ~$1.5 million (severance-related) | Item 7.01 Regulation FD Disclosure A press release detailing the company's new strategic direction was issued, with information furnished, not filed, under the Exchange Act - A press release was issued on August 5, 2025, titled "Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry"[10] - The information provided under Items 2.02 and 7.01 (including Exhibit 99.1) is considered "furnished" and not "filed" under the Exchange Act, limiting its legal liability under Section 18[11] Item 9.01 Financial Statements and Exhibits This section lists the exhibits accompanying the Form 8-K filing, with the press release on strategic direction as the primary exhibit Exhibits Filed | Exhibit | Description | | :--- | :--- | | 99.1 | Press Release issued by Allurion Technologies, Inc. on August 5, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |